The Trump administration has been talking to drugmakers about ways to raise prices of medicines in Europe and elsewhere to cut drug costs in the U.S.

The U.S. Food and Drug Administration on Thursday announced a new program to speed up construction and review of drug manufacturing plants in the country to boost domestic drug supply.

Starting August 7, President Trump's new tariffs threaten to significantly impact the pharmaceutical industry, potentially leading to higher drug prices and shortages in the U.S. Despite intentions to boost domestic production,